We are live on ! Find out more
VC

Vivo Capital Portfolio holdings

AUM $1.2B
1-Year Est. Return 911.44%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+911.44%
3 Year Est. Return
+7,373.93%
5 Year Est. Return
+10,475.15%
10 Year Est. Return
+136,503.27%
AUM
$996M
AUM Growth
-$456M
Cap. Flow
-$261M
Cap. Flow %
-26.18%
Top 10 Hldgs %
67.37%
Holding
55
New
1
Increased
2
Reduced
8
Closed
6

Top Buys

Rank Stock Value
1
ZLAB icon
Zai Lab
ZLAB
+$3.17M
2
RZLT icon
Rezolute
RZLT
+$1.63M
3
GTH
Genetron Holdings Limited ADS
GTH
+$1.22M

Top Sells

Rank Stock Value
1
NFH
New Frontier Health Corporation Ordinary Shares
NFH
+$171M
2
ASND icon
Ascendis Pharma A/S
ASND
+$27.9M
3
HRMY icon
Harmony Biosciences
HRMY
+$21.4M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$15M
5
TARS icon
Tarsus Pharmaceuticals
TARS
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 97.84%
2 Materials 2.16%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MREO
51
Mereo BioPharma
MREO
$51.9M
– –
-3,795,225
Closed -$4.25M
NKTX icon
52
Nkarta
NKTX
$162M
– –
-512,225
Closed -$5.83M
EIGR
53
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-139
Closed -$35K
DICE
54
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-163,136
Closed -$3.12M
NFH
55
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
– –
-14,300,000
Closed -$171M
1 2
3

Similar funds

SGDR
SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return

Vivo Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Vivo Capital held 55 positions worth $996M, down 31% from $1.45B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Vivo Capital withdrew a net $261M in Q2 2022, closing 6 positions and reducing 8 holdings. Its most notable exit was New Frontier Health Corporation Ordinary Shares, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 85% a quarter earlier, followed by Materials and Financials.

Against the trend, Vivo Capital opened a new position in Rezolute worth $1.58M.

  • Vivo Capital's largest Q2 2022 buy was Rezolute: 489,473 shares worth $1.58M.
  • Vivo Capital added most to Zai Lab in Q2 2022, an estimated $3.17M increase.
  • Vivo Capital's biggest Q2 2022 reduction was Ascendis Pharma A/S, cutting an estimated $27.9M.
  • Vivo Capital fully exited New Frontier Health Corporation Ordinary Shares in Q2 2022, selling an estimated $171M.
  • Vivo Capital's ten largest holdings make up 67% of its $996M portfolio in Q2 2022.
  • Vivo Capital opened 1 new position and closed 6 in Q2 2022.
  • Vivo Capital's portfolio value fell 31% quarter-over-quarter to $996M.

Based on Vivo Capital's 13F filing for Q2 2022, filed 15 Aug 2022.